| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 01/24/2008 | US20080021004 Sapogenin derivatives and their use in the treatment of cognitive dysfunction |
| 01/24/2008 | US20080020459 Progenitor cell populations, expansion thereof, and growth of non-hematopoietic cell types and tissues therefrom |
| 01/24/2008 | US20080020021 5-Hydroxysapogenin derivatives with anti-dementia activity |
| 01/24/2008 | US20080019986 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof |
| 01/24/2008 | US20080019915 including cystic fibrosis transmembrane conductance regulator ("CFTR"); N[6-(2-hydroxymethylphenyl-1yl)-5-methylpyrimidine][(4-methoxophenyl-1-yl)cyclopopyl]-amide; genetic disorders; respiratory system disorders, cystic fibrosis, hereditary emphysema and hemochromatosis, coagulation-fibrinolysis |
| 01/24/2008 | DE102007032612A1 Polymorphe Formen von Flupirtinmaleat Polymorphic forms of flupirtine maleate |
| 01/24/2008 | CA2658400A1 Drugs comprising an inhibitor of class 1 alpha mannosidase for the treatment of sarcoglycanopathies |
| 01/24/2008 | CA2658342A1 Therapeutic agent for amyotrophic lateral sclerosis |
| 01/23/2008 | EP1556354B1 Therapeutic piperazine derivates useful for treating pain |
| 01/23/2008 | EP1532144B1 quinuclidine derivatives and their use |
| 01/23/2008 | EP1339687B1 4-6-diphenyl pyridine derivatives as antiinflammatory agents |
| 01/23/2008 | EP1196404B1 Piperazine derivatives as modulators of chemokine receptor activity |
| 01/23/2008 | CN101108875A Growth hormone releasing peptides |
| 01/22/2008 | US7320968 Pharmaceutical composition |
| 01/22/2008 | US7320872 Genetically engineered nervous system cells for use in the treatment of alzheimer's, parkinson's, amyotrophic lateral sclerosis, multiple sclerosis, trauma, brain, muscle, cardiovascular, vision , liver, kidney and pancreas disorders |
| 01/22/2008 | US7320789 Antibody inhibitors of GDF-8 and uses thereof |
| 01/22/2008 | CA2392168C Vitamin d analogues |
| 01/22/2008 | CA2195419C Immunological activity of rhamnolipids |
| 01/17/2008 | WO2008007091A1 Method for reducing spasms comprising treatment with an agent that elevates the level of one or more cyclic nucleotides in the muscle |
| 01/17/2008 | WO2007084853A3 Methods for inhibiting osteoclastogenesis |
| 01/17/2008 | WO2007014051A3 Use of amylin and amylin agonists as cardioprotective or myoprotective agents |
| 01/17/2008 | US20080015185 N-heterocyclic inhibitors of tnf-alpha expression |
| 01/17/2008 | US20080015183 Substituted quinazolin-4-ylamine analogues |
| 01/17/2008 | US20080015172 Caspase inhibitors and uses thereof |
| 01/17/2008 | US20080015169 Amino-methyl substituted tetracycline compounds |
| 01/17/2008 | US20080014252 Topical compositions with long lasting effect |
| 01/17/2008 | US20080014228 Solid form |
| 01/17/2008 | US20080014197 Neutralizing human anti-igfr antibody |
| 01/16/2008 | EP1877557A2 Micro-rna's that regulate muscle cells |
| 01/16/2008 | EP1877075A2 Antibodies to myostatin |
| 01/16/2008 | EP1877058A2 Use of phycotoxins in veterinary applications |
| 01/16/2008 | CN100361665C Compositions and methods for treatment of mitochondrial diseases |
| 01/15/2008 | US7319160 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same |
| 01/15/2008 | US7319092 Methods of suppressing microglial activation |
| 01/15/2008 | CA2319763C Cholenic acid amides and pharmaceutical compositions thereof |
| 01/10/2008 | WO2008004610A1 Method of treating genetic disease caused by nonsense mutation |
| 01/10/2008 | WO2008004340A1 Senescence inhibitor |
| 01/10/2008 | WO2008004333A1 Agent for improving muscle power |
| 01/10/2008 | US20080009631 e.g. 2-[4-[3-[2-(2,4-Dichlorophenyl)-5-isopropyl-4-oxazolyl]propionyl]-2-methylphenoxy]-2-methylpropionic acid; |
| 01/10/2008 | US20080009525 Activator of peroxisome proliferator-activated receptor delta |
| 01/10/2008 | US20080009524 Such as 5'-(1-(2,2-Difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-2'-methyl-N-(methylsulfonyl)biphenyl-3-carboxamide; cystic fibrosis transmembrane conductance regulator disorders |
| 01/10/2008 | US20080009489 Androgen receptor modulators and method of treating disease using the same |
| 01/10/2008 | CA2648782A1 Method for administering tolperisone |
| 01/09/2008 | EP1876239A1 Degranulation inhibitor |
| 01/09/2008 | EP1875921A1 Dpp4 inhibitor and pharmaceutical application thereof |
| 01/09/2008 | EP1663262A4 Bowman-birk inhibitor compositions for treatment of muscular atrophy and degenerative muscle disease |
| 01/09/2008 | EP1527068B1 Novel arylimidazole derivatives, their use as no-syntase inhibitors and as modulators of sodium channels |
| 01/09/2008 | EP1465922B1 Corticotropin releasing factor receptor 2 agonists |
| 01/09/2008 | EP1263730B1 Amine derivatives for the treatment of apoptosis |
| 01/09/2008 | CN100360563C Recombinant VPAC2 receptor specific agonist RMBAY, its expression and use |
| 01/09/2008 | CN100360562C Recombinant VPAC2 receptor specific agonist RMROM, its expression and use |
| 01/08/2008 | US7317038 1,3-Diacetyl-8-hydroxy-2-(7-hydroxychromanon-3-yl)-9H-xanthen-9-ones; obtained from a culture of the Penicillium strain SPF-3059; prevents growth cone collapse |
| 01/08/2008 | US7317026 Sleep disorders; side effect reduction ; antihistamine antagonist |
| 01/08/2008 | US7317014 pyrimidine derivatives such as 4-Chloro-5,6-diphenyl-2-(trifluoromethyl)pyrimidine, used for the treatment of inflammation and immunological diseases |
| 01/08/2008 | US7317007 Such as 4-(4-Methoxy-7-morpholin-4-yl-benzothiazol-2-ylcarbamoyl)-piperidine-1-carboxylic acid tert-butyl ester; for prevention of illnesses based on the modulation of the adenosine system, such as Alzheimer's disease, Parkinson's disease, neuroprotection, schizophrenia, anxiety, pain |
| 01/08/2008 | US7316997 GH secretagogues and uses thereof |
| 01/08/2008 | CA2439291C Imidazo (1,2-a)-pyridine derivatives as mglur5 antagonists |
| 01/03/2008 | WO2008001016A1 Use of a carbonic anhydrase inhibitor for preparation of a drug for treating skeletal muscle degeneration |
| 01/03/2008 | WO2008000490A1 High frequency application of neurotoxic component of botulinum toxin |
| 01/03/2008 | US20080004435 Corticotropin releasing factor 2 receptor agonists |
| 01/03/2008 | US20080004335 Athletic Ability Enhancing Composition |
| 01/03/2008 | US20080004312 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists |
| 01/03/2008 | US20080004258 such as [2-(3,4-Dichloro-phenoxy)-5-(4-morpholin-4-yl-but-1-ynyl)-benzyl]-methyl-amine, used as H3 receptor and/or serotonin transporter modulators useful in the treatment of cognitive, sleep and psychological disorders |
| 01/03/2008 | US20080004219 Reducing a cholinergic influenced secretion; treating smooth muscle disorders such as spasms |
| 01/03/2008 | US20080003318 Reducing a cholinergic influenced secretion; treating smooth muscle disorders such as spasms |
| 01/03/2008 | US20080003290 Phenethanolamine Derivatives for Treatment of Respiratory Diseases |
| 01/03/2008 | US20080003198 Hernia treatment agents |
| 01/03/2008 | CA2654214A1 High frequency application of neurotoxic component of botulinum toxin |
| 01/02/2008 | EP1872786A1 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation |
| 01/02/2008 | EP1406859B1 Substituted 4-aminocyclohexanol derivatives |
| 01/02/2008 | EP1254130B1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 01/02/2008 | EP1124828B1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 01/02/2008 | CN200998435Y Tizanidine and the novel agent of the derivant thereof |
| 01/02/2008 | CN101095938A Chinese traditional medicine for treating diabetic ischemic muscular atrophy |
| 01/02/2008 | CN101095874A Chinese traditional medicine preparations for treating diabetes ischemic muscular atrophy |
| 01/02/2008 | CN101095839A Chinese patent drug for treating diabetes ischemic muscular atrophy |
| 01/02/2008 | CN101095818A Chinese traditional medicine composition for treating diabetes impotency |
| 01/02/2008 | CN101095731A Chinese traditional medicine for preventing and treating rheum |
| 01/02/2008 | CN100358577C Treatment of auto immune diseases with antagonists which bind to B cell surface markers |
| 01/01/2008 | US7314936 antiinflammatory agents; 1H-imidazo[4,5-b]pyridin-7-indole-2-yl- derivatives; autoimmune and proliferative disorders; inhibitors of cell adhesion molecule expression and inflammatory cytokine signal transduction; rheumatoid arthritis, ulcerative colitis/Crohn's disease, central nervous system diseases |
| 01/01/2008 | US7314934 Substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds, e.g., 8-(2,6-Difluoro-phenyl)-4-(4-fluoro-2-methyl-phenyl)-2-(2-hydroxy-1-hydroxymethyl-ethylamino)-8H-pyrido[2,3-d]pyrimidin-7-one; CSBP/p38 kinase inhibitors |
| 01/01/2008 | US7314889 Compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| 01/01/2008 | US7314881 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds |
| 01/01/2008 | US7314873 (Halo-benzo carbonyl)heterobi cyclic p38 linase inhibiting agents |
| 01/01/2008 | US7314870 Compounds, their preparation and use |
| 01/01/2008 | US7314618 Novel nucleic acids encoding a fibroblast growth factor-23(FGF23) and proteins encoded thereby, mutations in which are associated with autosomal dominant rickets (ADHR). The invention further relates to methods of diagnosis of |
| 01/01/2008 | US7314617 Platelet rich plasma, no exogenous activator; sodium bicarbonate buffer, citrate dextrose anticoagulant |
| 12/30/2007 | CA2558160A1 Antisense oligonucleotides for treatment of muscle wasting |
| 12/27/2007 | WO2007148711A1 N-(3,4-disubstituted phenyl)salicylamide derivative |
| 12/27/2007 | WO2007148494A1 Agent for increasing testosterone level |
| 12/27/2007 | US20070299075 e.g. 1-[4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-4-(aminosulfonyl)aminobutan-2-ol; inhibit the tyrosine kinase activity of endothelial and fibroblast growth factors receptors; angiogenesis inhibitor; anticarcinogenic agent |
| 12/27/2007 | US20070299070 Such as 5-(benzyloxy)-N-[4-(morpholinomethyl)phenyl]-1H-indole-2-carboxamide and 5-(benzyloxy)-N-[4-(morpholinomethyl)phenyl]-1H-benzimidazole-2-carboxamide; melanin-concentrating hormone receptor antagonist, useful for treating obesity |
| 12/27/2007 | US20070299035 Use of chemical chelators as reversal agents for drug-induced neuromuscular block |
| 12/27/2007 | US20070299008 Transport Protein Which Is Used To Introduce Chemical Compounds Into Nerve Cells |
| 12/27/2007 | US20070298039 Immunoglobulin specific to receptor protein DR5 for treatment of cancer, inflammatory or autoimmune diseases |
| 12/27/2007 | US20070298031 Methods for preventing or treating neuromuscular or muscular conditions by peripherally administered erythropoietin |
| 12/27/2007 | US20070298015 Treatment of Muscular Dystrophy with Mobilized Peripheral Blood Pluripotent Cells |
| 12/26/2007 | EP1870473A1 Adeno-associated virus-mediated delivery of angiogenic factors |
| 12/26/2007 | EP1491531B1 (1-indanone)-(1,2,3,6-tetrahydropyridine) derivative |
| 12/26/2007 | CN101091783A Preparation of Chinese traditional medicine for treating HIV infection, AIDS, tumours etc. multiple difficult diseases |